Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Clinical Pharmacology|January 1, 1987
Metabolism of desciclovir, a prodrug of acyclovir, in humans after multiple oral dosingH C Krasny, B G Petty
Advances in Experimental Medicine and Biology|January 1, 1977
Oxypurine and 6-thiopurine nucleoside triphosphate formation in human erythrocytesD J Nelson, C Bugge, H C Krasny
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1986
Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysisG M Shah, R L Winer, H C Krasny
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1995
Metabolism and pharmacokinetics of a double prodrug of ganciclovir in the rat and monkeyH C Krasny, L Beauchamp, T A Krenitsky, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1981
Pharmacokinetics and bioavailability of acyclovir in the dogH C Krasny, P de Miranda, M R Blum, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1981
The disposition of acyclovir in different speciesP de Miranda, H C Krasny, D A Page, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1983
Disposition in the dog and the rat of 2, 6-diamino-9-(2-hydroxyethoxymethyl)purine (A134U), a potential prodrug of acyclovirS S Good, H C Krasny, G B Elion, et al.
The American Journal of Medicine|July 20, 1982
Species differences in the disposition of acyclovirP de Miranda, H C Krasny, D A Page, et al.
The American Journal of Medicine|July 20, 1982
Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failureH C Krasny, S H Liao, P de Miranda, et al.
Clinical Pharmacology and Therapeutics|November 1, 1981
Disposition of intravenous radioactive acyclovirP de Miranda, S S Good, O L Laskin, et al.
Pageof 2